Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,656.00p
   
  • Change Today:
      12.00p
  • 52 Week High: 2,354.00
  • 52 Week Low: 1,630.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 1,957
  • Market Cap: £1,093.54m
  • RiskGrade: 128
  • Beta: 1.51

Genus scales back profit outlook on China, Brazil weakness

By Benjamin Chiou

Date: Wednesday 17 Jul 2024

LONDON (ShareCast) - (Sharecast News) - Genus saw its share price drop sharply on Wednesday after the animal genetics group said profits this year would be lower than expected due to ongoing market challenges in China and Brazil.
The company, which uses gene-editing and genomic science to improve breeding for lifestock farmers and food producers, said its PIC or pigs division performed in line with expectations over the fourth quarter ended 30 June, though the porcine market in China "continues to be challenging".

Meanwhile, in ABS, which comprises dairy and beef cattle operations, the company experienced lower volumes in the second half compared with last year, as weak demand persisted in several countries, most notably China and Brazil, which impacted profits.

Nevertheless, Genus still guided to a full-year adjusted pre-tax profit of between £58m and £61m, in line with market expectations. "This shortfall in ABS adjusted operating profits was offset by the realisation of early savings as a result of actions taken following the R&D strategic review completed in February 2024," the company said.

Genus said it expects a "significant improvement" in ABS's profit position in the current financial year. However, both ABS volumes and the group's overall adjusted operating profit are estimated to be lower than previously estimated in the year ending June 2025 "due to the continuation of weak demand in several countries, including China and Brazil".

The stock was down 5.8% at 1,794p by 0906 BST.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,656.00p
Change Today 12.00p
% Change 0.73 %
52 Week High 2,354.00
52 Week Low 1,630.00
Volume 1,957
Shares Issued 66.03m
Market Cap £1,093.54m
Beta 1.51
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
82.13% below the market average82.13% below the market average82.13% below the market average82.13% below the market average82.13% below the market average
84% below the sector average84% below the sector average84% below the sector average84% below the sector average84% below the sector average
Price Trend Not Available
Income
77.54% below the market average77.54% below the market average77.54% below the market average77.54% below the market average77.54% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
95.74% below the market average95.74% below the market average95.74% below the market average95.74% below the market average95.74% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 07-Nov-24 29-Feb-24
Paid 06-Dec-24 28-Mar-24
Amount 21.70p 10.30p

Trades for 22-Nov-2024

Time Volume / Share Price
08:37 7 @ 1,656.00p
08:37 3 @ 1,656.00p
08:37 15 @ 1,656.00p
08:30 800 @ 1,650.97p
08:30 37 @ 1,654.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page